Sonoma Pharmaceuticals, Inc. (SNOA) Stock Forecast
SNOA analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $12.00 average of analyst targets
- Upside to target
- +971.4% from the latest close
- Next earnings
- November 3, 2026
- 52-week range
- $1.01 – $4.00
SNOA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SNOA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (FY2027) | −$0.56 | −$0.56 | −$0.56 | −$1.61 | +65.2% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SNOA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (FY2027) | $23.9M | $23.9M | $23.9M | +15.8% | 1 |
SNOA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SNOA revenue: reported and forecast
SNOA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (FY2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.56 | — | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SNOA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SNOA beat in 4 of 10.
What analysts expect from SNOA
The average price target is $12.00, 971.4% above the latest close of $1.12. For FY2027 the average estimate is −$0.56 per share on revenue of $23.9 million. Sonoma Pharmaceuticals beat the EPS estimate in 4 of the last 10 quarters.
Related: SNOA income statement, SNOA key metrics, SNOA chart. See the SNOA stock overview for the latest quote and news.
SNOA forecast FAQ
What is Sonoma Pharmaceuticals's price target?
The average analyst price target for Sonoma Pharmaceuticals is $12.00, 971.4% above the latest close of $1.12.
When does Sonoma Pharmaceuticals report earnings?
Sonoma Pharmaceuticals is expected to report results for the quarter ending September 30, 2026 on November 3, 2026.
Does Sonoma Pharmaceuticals usually beat earnings estimates?
Sonoma Pharmaceuticals reported EPS at or above the analyst estimate in 4 of the last 10 quarters.